Johnson & johnson vaccine

So far, the “variant of interest” has been detected in 29 countries, and it may spread more quickly than milder versions of the coronavirus.

The U.S. Food and Drug Administration (FDA) put out a warning about the Janssen (Johnson & Johnson) COVID-19 vaccine after about 100 cases of a nerve condition were identified in people two weeks after inoculation. The nerve condition is called Guillain-Barre Syndrome or GBS. The body’s immune system damages nerve cells, causing muscle weakness or paralysis in the most...

The CDC confirmed Monday that about 100 cases of Guillain-Barré syndrome, a rare neurological disorder, were found in people who had received the Johnson & Johnson vaccine.

Hartford Healthcare is gearing up to resume giving out the Johnson & Johnson COVID-19 vaccine. “We’re excited to be able to get back to doing that,” said Dr. James Cardon, Hartford Healthcare Executive Vice President. Recently the CDC and FDA announced a nationwide hold was lifted after 11 days. That came amid reports of rare but severe blood clots in…

The Johnson & Johnson COVID-19 vaccine is back in the mix again. It was put on pause a little less than two weeks ago when at least six women had rare blood clots after getting the shot and one of them died.

After the CDC and FDA announced on Friday that the pause on the Johnson & Johnson vaccine would be lifted, CDC director Rochelle Walensky vouched for its safety and efficacy despite extremely rare serious side effects. “The [Johnson & Johnson vaccine] is an important vaccine offering key advantages, including its single-dose option and its viability when the supply chain may...

Federal health officials meet Friday to discuss the pause of using the J&J Janssen coronavirus vaccine. The pause was because of extremely rare blood clots in some patients. Could the vaccine return to market with the right disclaimer or message of caution? Peter Pitts, former FDA associate commissioner, explains.

The Johnson & Johnson vaccine pause gives medical authorities time to investigate the rare cases of blood clots and determine the cause. Dr. Jennifer Haythe, co-director of Columbia Women’s Heart Center, explains that this type of blood clot requires a different treatment than a typical clot, and symptoms to look out for.

The FDA’s decision to pause use of the Johnson & Johnson COVID-19 vaccine has left clinics and pharmacies around the United States, including in Connecticut, to adjust.

The FDA and CDC pausing use of the J& Janssen vaccine sends a signal to doctors across the nation to look out for the rare blood clots that occurred in 6 women out of millions of patients who received this brand of vaccine, and come up with guidance for how to treat those clots, NBC News senior medical correspondent Dr....

Many cities were relying on the Johnson & Johnson vaccine for mobile or walkup clinics, but now have to shift their efforts.

The Johnson and Johnson Janssen vaccine has been useful – it’s one dose and doesn’t need ultracold storage. Former FDA Associate Commissioner Peter Pitts weighs in after the FDA and CDC suspended use of the vaccine amid rare reports of blood clots.

The state will receive a much lower number of Johnson & Johnson COVID-19 vaccines next week after the company reported production problems, and the supply issue could affect clinics.

There’s a lot of confusion over what over-the-counter medication is allowed after getting the coronavirus vaccine. Here’s what you need to know before you get your shot.